ALPS Medical Breakthroughs ETF (SBIO) targets late-stage clinical biotech firms poised for FDA approval or acquisition, offering high-risk, high-reward exposure. SBIO surged 91% over the past year, ...

Biotech investment is being driven by medical demand, advances in drug development and pharmaceutical demand for new ...

Medical bioengineering is reshaping modern healthcare by merging biology, engineering, and advanced computational systems to create precise and personalized treatments. Through innovations like CRISPR ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

ALPS Medical Breakthroughs ETF targets late-stage clinical trial biotechs primed for outsized performance and M&A. SBIO’s selective criteria focus on U.S.-listed firms with strong cash positions, ...

Charlotte Owens, M.D., spends a lot of time flying across the country to lead in two very different roles. In South San Francisco, she leads medical affairs at Genentech, which emerged as the world’s ...

Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of life itself, as researchers learn to build quantum behavior directly into ...

Austin, Texas, September 24th, 2026, FinanceWireVERAXA Biotech (NASDAQ: VRXA) is shifting its focus to advancing its ...